Ozmosis Announces Launch of ArcheMedX to Disrupt Medical Education

Washington, DC (PRWEB) March 05, 2013

Ozmosis, Inc., a leading provider of social business software and care collaboration solutions to the healthcare industry, announced the spin out of ArcheMedX, a healthcare informatics and e-learning technology company delivering collaborative learning solutions to improve medical education. Given the explosive growth of its education business, Ozmosis has also announced that Joel Selzer, Co-Founder & Chairman of Ozmosis, will lead ArcheMedX as CEO. Ike Brenner, Founder and Former CEO of Prematics, will assume day-to-day leadership of Ozmosis.

“By spinning out ArcheMedX, we are extending the benefits of Ozmosis to the education market and fundamentally disrupting the learning and assessment model in healthcare”, said Joel Selzer, Chairman of Ozmosis and CEO of ArcheMedX, “and with Ike now leading Ozmosis, both businesses are well positioned to accelerate growth and adoption.”

Based on the clinical informatics and collaboration technology developed by Ozmosis and the research and expertise of Brian S. McGowan, PhD, ArcheMedX (/ärk’ – ki – med – ics/) has engineered a learning architecture that encourages clinicians to conduct their natural learning actions either individually, as part of a cohort, or within a broader collaborative learning network. “Clinicians are busy and increasingly overwhelmed by emergent medical knowledge and educational content. By centralizing the natural learning actions of clinicians in a single platform, we can now ensure that lessons learned once, can be learnt permanently,” said Brian S McGowan PhD, Co-founder and Chief Learning Officer of ArcheMedX.

With more than a decade as a medical educator and educational research scientist working both within Academia and Industry, Brian ensures that ArcheMedX will be a leading voice in a new era of connected learning. Coupled with Joel’s experience running Ozmosis, one of the world’s leading physician social networking and care collaboration companies, Brian and Joel bring a deep understanding to ArcheMedX of how health care professionals use emerging technologies to access information, share knowledge and engage in collaborative learning activities.

Despite the significant funding devoted to developing well-designed educational content, today’s continuing medical education (CME) courses struggle to improve medical competency. The Institute of Medicine (IOM) views the traditional CME model to be “broken” and has called for a “new, comprehensive vision” for professional development in the health professions. ArcheMedX answers this call by organizing and connecting disparate learning actions in a single system; thereby enabling clinicians to more easily extract critical insights and apply more meaningful lessons to clinical practice.

—

About ArcheMedX
ArcheMedX is a healthcare informatics and e-learning technology company with the singular mission to build the structure required to transform medical education through new connected learning and assessment models. By engineering an informatics-powered architecture that organizes and connects the natural learning actions of clinicians in one system, ArcheMedX simplifies lifelong learning and streamlines the process of educational planning, assessment and support. Visit https://archemedxinc.wpengine.com for more information.

About Ozmosis
Ozmosis is a provider of social business software and care collaboration solutions to the healthcare industry. Its enterprise platform, OzmosisESP, enables hospitals, healthcare systems and healthcare service organizations to facilitate collaboration and communication around any targeted content, user groups, and workflow. At the heart of OzmosisESP is a model for clinical communication and collaborative care that weaves a healthcare organization’s social strategy and tools into its underlying content and workflows, enabling staff and clinicians to collaborate seamlessly with anyone, anytime and from anywhere. Visit http://ozmosis.com for more information.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/3/prweb10460615.htm